Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2170638rdf:typepubmed:Citationlld:pubmed
pubmed-article:2170638lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2170638lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:2170638lifeskim:mentionsumls-concept:C0001455lld:lifeskim
pubmed-article:2170638lifeskim:mentionsumls-concept:C1820156lld:lifeskim
pubmed-article:2170638lifeskim:mentionsumls-concept:C1508748lld:lifeskim
pubmed-article:2170638pubmed:issue2lld:pubmed
pubmed-article:2170638pubmed:dateCreated1990-11-19lld:pubmed
pubmed-article:2170638pubmed:abstractTextSeveral aspects of cyclic AMP second messenger signal generation were examined in EBV-transformed cell lines from 12 schizophrenic patients and 12 age- and sex-matched controls. No evidence was obtained suggesting a heritable abnormality in cyclic AMP synthesis in schizophrenia. Basal, forskolin, A1/NaF- and GppNHp-stimulated cyclic AMP synthesis in membranes from transformed cell lines was identical for schizophrenic and control subjects. In addition, no significant differences were observed for basal, forskolin-, isoproterenol- and prostaglandin E1-stimulated cyclic AMP accumulation in intact cell lines derived from ten of the schizophrenic patients compared with cell lines derived from ten of the control subjects.lld:pubmed
pubmed-article:2170638pubmed:languageenglld:pubmed
pubmed-article:2170638pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2170638pubmed:citationSubsetIMlld:pubmed
pubmed-article:2170638pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2170638pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2170638pubmed:statusMEDLINElld:pubmed
pubmed-article:2170638pubmed:issn0022-3956lld:pubmed
pubmed-article:2170638pubmed:authorpubmed-author:EbsteinR PRPlld:pubmed
pubmed-article:2170638pubmed:authorpubmed-author:YedgarSSlld:pubmed
pubmed-article:2170638pubmed:authorpubmed-author:LererBBlld:pubmed
pubmed-article:2170638pubmed:authorpubmed-author:SilverHHlld:pubmed
pubmed-article:2170638pubmed:authorpubmed-author:BennettE RERlld:pubmed
pubmed-article:2170638pubmed:authorpubmed-author:HadjezJJlld:pubmed
pubmed-article:2170638pubmed:issnTypePrintlld:pubmed
pubmed-article:2170638pubmed:volume24lld:pubmed
pubmed-article:2170638pubmed:ownerNLMlld:pubmed
pubmed-article:2170638pubmed:authorsCompleteYlld:pubmed
pubmed-article:2170638pubmed:pagination121-7lld:pubmed
pubmed-article:2170638pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2170638pubmed:meshHeadingpubmed-meshheading:2170638-...lld:pubmed
pubmed-article:2170638pubmed:meshHeadingpubmed-meshheading:2170638-...lld:pubmed
pubmed-article:2170638pubmed:meshHeadingpubmed-meshheading:2170638-...lld:pubmed
pubmed-article:2170638pubmed:meshHeadingpubmed-meshheading:2170638-...lld:pubmed
pubmed-article:2170638pubmed:meshHeadingpubmed-meshheading:2170638-...lld:pubmed
pubmed-article:2170638pubmed:meshHeadingpubmed-meshheading:2170638-...lld:pubmed
pubmed-article:2170638pubmed:meshHeadingpubmed-meshheading:2170638-...lld:pubmed
pubmed-article:2170638pubmed:meshHeadingpubmed-meshheading:2170638-...lld:pubmed
pubmed-article:2170638pubmed:meshHeadingpubmed-meshheading:2170638-...lld:pubmed
pubmed-article:2170638pubmed:year1990lld:pubmed
pubmed-article:2170638pubmed:articleTitleCyclic AMP second messenger signal generation in EBV-transformed lymphoblastoid cells from schizophrenic patients.lld:pubmed
pubmed-article:2170638pubmed:affiliationDepartment of Psychiatric Research, Ezrath Nashim Hospital, Jerusalem, Israel.lld:pubmed
pubmed-article:2170638pubmed:publicationTypeJournal Articlelld:pubmed